Human Reproduction, Vol. 17, No. 8, 2085-2088,
August 2002
© 2002 European Society of Human Reproduction and Embryology
Hepatitis C virus infection and assisted reproduction
1 Departments of Obstetrics and Gynaecology and 2 Paediatrics, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, 90035–003, Brasil
BACKGROUND: In assisted reproduction, hepatitis C virus (HCV) transmission may pose a risk for the baby, technicians, and gametes or embryos from non-contaminated parents. This study aimed at determining the prevalence and risk factors for HCV infection in a group of infertile couples. METHODS: HCV infection was investigated in 409 patients attending the infertility clinic at Hospital de Clínicas de Porto Alegre, Brazil, between 1997 and 1998. Serum was screened for anti-HCV using ELISA and for hepatitis B surface antigen (HBsAg) using an enzyme-linked fluorescent assay (ELFA). HCV infection and semen viraemia was also investigated using HCV RNA detection. RESULTS: The overall prevalence of anti-HCV was 3.2% (8/248) among women and 3.7% (6/161) among men. All subjects were negative for hepatitis B virus (HBV) and human immunodeficiency virus (HIV). From the 14 HCV-positive patients, two were lost, and serum was collected from the remaining 12 patients for assessment of HCV RNA, resulting in five HCV-positive cases (one woman and four men). Only one of the HCV-positive men had viraemia levels >500 000 RNA copies/ml. There was a significant risk associated with being HCV-positive in women with HCV-positive male partners (P < 0.001). In male patients, the correlation between use of intravenous drugs and HCV-positivity was also significant (P < 0.001). CONCLUSIONS: Since the risk for vertical and laboratory HCV infection is not well determined, and HCV prevalence is not negligible in this group, we recommend that infertile patients be screened before assisted reproductive techniques.
Key words: hepatopathy/infertility/in-vitro fertilization/non-A non-B hepatitis
3 To whom correspondence should be addressed at: Setor de Reproducião Humana, Hospital de Clinicas de Porto Alegre, Ramiro Barcelos 2350 Sala 1125, 90035–003, Porto Alegre, Brasil. E-mail: epp{at}via-rs.net
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M E COCCIA, F CAMMILLI, L GINOCCHIONI, and F RIZZELLO Role of Infection in In Vitro Fertilization Treatment Ann. N.Y. Acad. Sci., December 1, 2004; 1034(1): 219 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Manno, E. Marchesan, M. Crovatto, P. Martelli, F. Tomei, and V. Adamo Preliminary evidence on the safety of ICSI with testicular spermatozoa in HCV-infected male: a case report Hum. Reprod., August 1, 2003; 18(8): 1666 - 1668. [Abstract] [Full Text] [PDF]
|
|